Aktie A3ETX8 AMPIO PHARMACEUTICALS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Ampio Pharmaceuticals, Inc.

Aktien

A3ETX8

US03209T3077

AMPE

Markt geschlossen - OTC Markets
Andere Börsenplätze
 18:51:37 03.05.2024 		% 5 Tage % 1. Jan.
0,255 USD +1,19 % Intraday Chart für Ampio Pharmaceuticals, Inc. -20,56 % -87,56 %
27.03. Ampio Pharmaceuticals, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
26.03. Top-Mittagskursrückgänge MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index
Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Top Midday Decliners
US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings
Top Premarket Decliners
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Durable Goods, Consumer Confidence Data
Ampio Pharmaceuticals Takes Voluntary Decision to Delist From NYSE American; Shares Plunge Premarket
North American Morning Briefing : Stocks Struggle After New Records
Ampio Pharmaceuticals, Inc. Provides Update on Results from Pre-IND Enabling Studies
Thinking about buying stock in Fusion Pharmaceuticals, Aptevo Therapeutics, Blink Charging, Ampio Pharmaceuticals, or Bitcoin Depot?
Wall Street Set to Open Lower Friday as Investors Await Economic Data, Powell Speech
Top Premarket Decliners
Thinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly Group ?
Top Premarket Gainers
Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Ampio Pharmaceuticals, Inc. Contemplates Bankruptcy .
Ampio Picks Ascendia Pharmaceuticals to Support OA-201's Clinical Development
Ampio Pharmaceuticals to Effect 20-to-1 Reverse Stock Split
Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Ampio Pharmaceuticals, Inc. Announces Change of Principal Executive Office
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3ETX8 Aktie
  4. Nachrichten Ampio Pharmaceuticals, Inc.
  5. Andere Sprachen